Predictors of biologic treatment of psoriasis: a non-interventional study

References

• NestleFOKaplanDHBarkerJNPsoriasisN Engl J Med200936149650919641206
   PubMed Web of Science ®Google Scholar
• PathiranaDOrmerodADSaiagPEuropean S3-guidelines on the systemic treatment of psoriasis vulgarisJ Eur Acad Dermatol Venereol200923Suppl 217019712190
   PubMed Web of Science ®Google Scholar
• de JongEMSeegersBAGulinckMKBoezemanJBvan de KerkhofPCPsoriasis of the nails associated with disability in a large number of patients: results of a recent interview with 1,728 patientsDermatology199619343003038993953
   PubMed Web of Science ®Google Scholar
• SalomonJSzepietowskiJCProniewiczAPsoriatic nails: a prospective clinical studyJ Cutan Med Surg20037431732112879333
   PubMed Web of Science ®Google Scholar
• AugustinMReichKBlomeCSchäferILaassARadtkeMANail psoriasis in Germany: epidemiology and burden of diseaseBr J Dermatol2010163358058520456340
   PubMed Web of Science ®Google Scholar
• PreySPaulCBronsardVAssessment of risk of psoriatic arthritis in patients with plaque psoriasis: a systematic review of the literatureJ Eur Acad Dermatol Venereol201024Suppl 2313520443998
   PubMed Web of Science ®Google Scholar
• AugustinMReichKGlaeskeGSchaeferIRadtkeMCo-morbidity and age-related prevalence of psoriasis: analysis of health insurance data in GermanyActa Derm Venereol201090214715120169297
   PubMed Web of Science ®Google Scholar
• PreySPaulCBronsardVCardiovascular risk factors in patients with plaque psoriasis: a systematic review of epidemiological studiesJ Eur Acad Dermatol Venereol201024Suppl 2233020443997
   PubMed Web of Science ®Google Scholar
• DreiherJWeitzmanDDavidoviciBShapiroJCohenADPsoriasis and dyslipidaemia: a population-based studyActa Derm Venereol200888656156519002339
   PubMed Web of Science ®Google Scholar
• CohenADWeitzmanDDreiherJPsoriasis and hypertension: a case-control studyActa Derm Venereol2010901232620107721
   PubMed Web of Science ®Google Scholar
• TamLSTomlinsonBChuTTCardiovascular risk profile of patients with psoriatic arthritis compared to controls – the role of inflammationRheumatology200847571872318400833
   PubMed Web of Science ®Google Scholar
• MenterAKormanNJElmetsCAGuidelines of care for the management of psoriasis and psoriatic arthritis. Section 5. Guidelines of care for the treatment of psoriasis with phototherapy and photochemotherapyJ Am Acad Dermatol201062111413519811850
   PubMed Web of Science ®Google Scholar
• European Medicines AgencyUstekinumab (Stelara) Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000958/human_med_001065.jsp&murl=menus/medicines/medicines.jsp&jsenabled=trueAccessed December 5, 2013
   Google Scholar
• European Medicines AgencyAdalimumab (Humira) Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000481/smops/Positive/human_smop_000184.jsp&murl=menus/medicines/medicines.jsp&mid=WC0b01ac058001d127Accessed December 5, 2013
   Google Scholar
• European Medicines AgencyInfliximab (Remicade) Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000240/human_med_001023.jsp&murl=menus/medicines/medicines.jsp&mid=WC0b01ac058001d124&jsenabled=trueAccessed December 5, 2013
   Google Scholar
• European Medicines AgencyEtanercept (Enbrel) Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000262/human_med_000764.jsp&mid=WC0b01ac058001d125&murl=menus/medicines/medicines.jsp&jsenabled=trueAccessed December 5, 2013
   Google Scholar
• SmithCHAnsteyAVBarkerJNBritish Association of Dermatologists’ guidelines for biologic interventions for psoriasis 2009Br J Dermatol20091615987101919857207
   PubMed Web of Science ®Google Scholar
• MrowietzUKragballeKReichKDefinition of treatment goals for moderate-severe psoriasis: a European consensusArch Dermatol Res2011303111020857129
   PubMed Web of Science ®Google Scholar
• National Institute of Health and Clinical ExcellenceInfliximab for the treatment of adults with psoriasis2008NICE technology appraisal guidance 134 Available from: http://www.nice.org.uk/nicemedia/pdf/ta134guidance.pdfAccessed December 5, 2013
   Google Scholar
• FredrikssonTPetterssonUSevere psoriasis – oral therapy with a new retinoidDermatologica19781574238244357213
   PubMedGoogle Scholar
• AugustinMReichKReichCQuality of psoriasis care in Germany – results of the national study PsoHealth 2007J Dtsch Dermatol Ges20086864064518801145
   PubMed Web of Science ®Google Scholar
• PalotaTSzepietowskiJCPecJA survey of disease severity, quality of life, and treatment patterns of biologically naive patients with psoriasis in central and eastern EuropeActa Dermatovenerol Croat201018315116120887696
   PubMed Web of Science ®Google Scholar
• KurdSKGelfandJMThe prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003–2004J Am Acad Dermatol200960221822419022533
   PubMed Web of Science ®Google Scholar
• MahlerRJacksonCIjacuHThe burden of psoriasis and barriers to satisfactory care: results from a Canadian patient surveyJ Cutan Med Surg200913628329319919805
   PubMed Web of Science ®Google Scholar
• PatelVHornEJLoboscoSJFoxKMStevensSRLebwohlMPsoriasis treatment patterns: results of a cross-sectional survey of dermatologistsJ Am Acad Dermatol200858696496918378352
   PubMed Web of Science ®Google Scholar
• PuigLCarrascosaJMCarreteroGSpanish evidence-based guidelines on the treatment of psoriasis with biologic agents, 2013. Part 1: On efficacy and choice of treatmentActas Dermosifiliogr2013104869470924018211
   PubMedGoogle Scholar
• SfikakisPPThe first decade of biologic TNF antagonists in clinical practice: lessons learned, unresolved issues and future directionsCurr Dir Autoimmun20101118021020173395
   PubMedGoogle Scholar
• HébertHLAliFRBowesJGriffithsCEBartonAWarrenRBGenetic susceptibility to psoriasis and psoriatic arthritis: implications for therapyBr J Dermatol2012166347448222050552
   PubMed Web of Science ®Google Scholar
• GlintborgBØstergaardMDreyerLTreatment response, drug survival, and predictors thereof in 764 patients with psoriatic arthritis treated with anti-tumor necrosis factor alpha therapy: results from the nationwide Danish DANBIO registryArthritis Rheum201163238239021279995
   PubMed Web of Science ®Google Scholar
• IervolinoSDi MinnoMNPelusoRPredictors of early minimal disease activity in patients with psoriatic arthritis treated with tumor necrosis factor-alpha blockersJ Rheumatol201239356857322247361
   PubMed Web of Science ®Google Scholar
• Van den BoschFMangerBGoupillePEffectiveness of adalimumab in treating patients with active psoriatic arthritis and predictors of good clinical responses for arthritis, skin and nail lesionsAnn Rheum Dis201069239439919815494
   PubMed Web of Science ®Google Scholar